002107 沃华医药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)9.2114.8457.57413.70420.071
总资产报酬率 ROA (%)6.5323.4175.2369.49912.910
投入资产回报率 ROIC (%)9.0714.7627.40713.41917.752

边际利润分析
销售毛利率 (%)75.12472.56874.44475.27877.471
营业利润率 (%)10.9725.8376.21111.06720.440
息税前利润/营业总收入 (%)10.4984.9485.44710.47020.063
净利润/营业总收入 (%)9.4414.4205.1278.85717.113

收益指标分析
经营活动净收益/利润总额(%)90.55498.95596.089101.503102.366
价值变动净收益/利润总额(%)1.1980.0000.0000.0000.000
营业外收支净额/利润总额(%)-0.071-4.545-3.389-1.373-1.437

偿债能力分析
流动比率 (X)2.2422.2422.3372.1143.046
速动比率 (X)1.8991.7991.8191.5992.232
资产负债率 (%)27.21326.66027.18828.20019.966
带息债务/全部投入资本 (%)-1.321-0.998-1.269-0.599-2.035
股东权益/带息债务 (%)-7,484.896-9,831.621-7,754.132-16,202.462-4,847.630
股东权益/负债合计 (%)261.194265.365258.738240.651354.018
利息保障倍数 (X)-22.493-7.779-9.715-23.373-228.748

营运能力分析
应收账款周转天数 (天)27.30733.60839.07437.47439.876
存货周转天数 (天)166.781220.119228.542223.809237.783